US FDA accepts MS drug Lemtrada resubmission for review
US FDA accepts MS drug Lemtrada resubmission for review
The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1904 Views
-
Last post by frodo
-
- 0 Replies
- 1259 Views
-
Last post by NHE
-
- 0 Replies
- 1685 Views
-
Last post by frodo
-
- 0 Replies
- 1234 Views
-
Last post by frodo
-
- 1 Replies
- 1752 Views
-
Last post by frodo
-
- 0 Replies
- 2051 Views
-
Last post by NHE
-
- 0 Replies
- 2414 Views
-
Last post by NHE
-
- 0 Replies
- 1069 Views
-
Last post by frodo
-
- 1 Replies
- 1465 Views
-
Last post by NHE